GoHealth, Inc.GOCONASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -10.41% | +40.63% | +19.06% | -11.17% | -71.10% |
| Gross Profit Growth | -1.32% | +42.99% | +33.79% | -27.65% | -85.13% |
| EBITDA Growth | +0.00% | +146.06% | +48.14% | +0.00% | -531.51% |
| Operating Income Growth | +0.00% | +432.98% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -2547.91% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -2431.03% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -3039.13% |
| Weighted Average Shares Growth | +6.20% | +5.95% | +6.77% | +6.32% | +17.93% |
| Weighted Average Shares Diluted Growth | +53.65% | +70.84% | +6.77% | +6.32% | -18.49% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -288.11% | -79.52% | -199.14% | +0.00% | +0.00% |
| Free Cash Flow Growth | -636.28% | -81.14% | -294.23% | +0.00% | +0.00% |
| Receivables Growth | -7.07% | -3.45% | -23.54% | -17.57% | -13.81% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -6.70% | -0.74% | -0.95% | +4.29% | -23.16% |
| Book Value per Share Growth | -10.31% | -0.74% | +0.26% | -8.60% | -78.11% |
| Debt Growth | -3.77% | -2.78% | -0.99% | +20.41% | +28.59% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +19.14% | +30.99% | +29.24% | -8.11% | -27.64% |